Prognostic Value of CYP1A2 (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients

1. Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., & He, J. X. (2019). & Zhong, NS (2020). Clinical characteristics of coronavirus disease, 1708–1720. GuanW. J. NiZ. Y. HuY. LiangW. H. OuC. Q. HeJ. X. 2019 ZhongNS 2020 Clinical characteristics of coronavirus disease 1708 1720 Search in Google Scholar

2. Wu, Y., Ho, W., Huang, Y., Jin, D. Y., Li, S., Liu, S. L., ... & Zheng, Z. M. (2020). SARS-CoV-2 is an appropriate name for the new coronavirus. The Lancet, 395(10228), 949–950. WuY. HoW. HuangY. JinD. Y. LiS. LiuS. L. ZhengZ. M. 2020 SARS-CoV-2 is an appropriate name for the new coronavirus The Lancet 395 10228 949 950 Search in Google Scholar

3. Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta bio medica: Atenei parmensis, 91(1), 157. CucinottaD. VanelliM. 2020 WHO declares COVID-19 a pandemic Acta bio medica: Atenei parmensis 91 1 157 Search in Google Scholar

4. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. ZhuN. ZhangD. WangW. LiX. YangB. SongJ. TanW. 2020 A novel coronavirus from patients with pneumonia in China, 2019 New England journal of medicine Search in Google Scholar

5. Bedford, J., Enria, D., Giesecke, J., Heymann, D. L., Ihekweazu, C., Kobinger, G., ... & Wieler, L. H. (2020). WHO Strategic and Technical Advisory Group for Infectious Hazards. COVID-19: towards controlling of a pandemic. Lancet, 395(10229), 1015–1018. BedfordJ. EnriaD. GieseckeJ. HeymannD. L. IhekweazuC. KobingerG. WielerL. H. 2020 WHO Strategic and Technical Advisory Group for Infectious Hazards COVID-19: towards controlling of a pandemic Lancet 395 10229 1015 1018 Search in Google Scholar

6. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497–506. HuangC. WangY. LiX. RenL. ZhaoJ. HuY. CaoB. 2020 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China The lancet 395 10223 497 506 Search in Google Scholar

7. Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The lancet, 395(10229), 1033–1034. MehtaP. McAuleyD. F. BrownM. SanchezE. TattersallR. S. MansonJ. J. 2020 COVID-19: consider cytokine storm syndromes and immunosuppression The lancet 395 10229 1033 1034 Search in Google Scholar

8. Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 20(6), 363–374. TayM. Z. PohC. M. RéniaL. MacAryP. A. NgL. F. 2020 The trinity of COVID-19: immunity, inflammation and intervention Nature Reviews Immunology 20 6 363 374 Search in Google Scholar

9. Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020). Severe COVID-19. New England Journal of Medicine, 383(25), 2451–2460. BerlinD. A. GulickR. M. MartinezF. J. 2020 Severe COVID-19 New England Journal of Medicine 383 25 2451 2460 Search in Google Scholar

10. Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ... & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 395(10229), 1054–1062. ZhouF. YuT. DuR. FanG. LiuY. LiuZ. CaoB. 2020 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study The lancet 395 10229 1054 1062 Search in Google Scholar

11. Tobin, M. J., Laghi, F., & Jubran, A. (2020). Why COVID-19 silent hypoxemia is baffling to physicians. American journal of respiratory and critical care medicine, 202(3), 356–360. TobinM. J. LaghiF. JubranA. 2020 Why COVID-19 silent hypoxemia is baffling to physicians American journal of respiratory and critical care medicine 202 3 356 360 Search in Google Scholar

12. Liu, Y., Lv, J., Liu, J., Li, M., Xie, J., Lv, Q., ... & Huang, B. (2020). Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19. Cell Research, 30(12), 1078–1087. LiuY. LvJ. LiuJ. LiM. XieJ. LvQ. HuangB. 2020 Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 Cell Research 30 12 1078 1087 Search in Google Scholar

13. Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama, 323(18), 1824–1836. SandersJ. M. MonogueM. L. JodlowskiT. Z. CutrellJ. B. 2020 Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review Jama 323 18 1824 1836 Search in Google Scholar

14. Almazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017). Drug metabolism in the liver. Clinics in liver disease, 21(1), 1–20. AlmazrooO. A. MiahM. K. VenkataramananR. 2017 Drug metabolism in the liver Clinics in liver disease 21 1 1 20 Search in Google Scholar

15. Wang, K., Zuo, P., Liu, Y., Zhang, M., Zhao, X., Xie, S., ... & Liu, C. (2020). Clinical and laboratory predictors of in-hospital mortality in patients with coronavirus disease-2019: a cohort study in Wuhan, China. Clinical infectious diseases, 71(16), 2079–2088. WangK. ZuoP. LiuY. ZhangM. ZhaoX. XieS. LiuC. 2020 Clinical and laboratory predictors of in-hospital mortality in patients with coronavirus disease-2019: a cohort study in Wuhan, China Clinical infectious diseases 71 16 2079 2088 Search in Google Scholar

16. Ramos-Lopez, O., Daimiel, L., Ramírez de Molina, A., Martínez-Urbistondo, D., Vargas, J. A., & Martínez, J. A. (2020). Exploring host genetic polymorphisms involved in SARS-CoV infection outcomes: Implications for personalized medicine in COVID-19. International journal of genomics, 2020. Ramos-LopezO. DaimielL. Ramírez de MolinaA. Martínez-UrbistondoD. VargasJ. A. MartínezJ. A. 2020 Exploring host genetic polymorphisms involved in SARS-CoV infection outcomes: Implications for personalized medicine in COVID-19 International journal of genomics 2020 Search in Google Scholar

17. Keyvani, H., Zahednasab, H., Sholeh, M., Mirzaei, R., Esghaei, M., & Karampoor, S. (2020). Gender Preponderance Might be Associated with the Severity of COVID-19 Infection. J Clin Cell Immunol, 11, 598. KeyvaniH. ZahednasabH. SholehM. MirzaeiR. EsghaeiM. KarampoorS. 2020 Gender Preponderance Might be Associated with the Severity of COVID-19 Infection J Clin Cell Immunol 11 598 Search in Google Scholar

18. Karampoor, S., Afrashteh, F., & Laali, A. (2021). Persistent hiccups after treatment of COVID-19 with dexamethasone: A case report. Respiratory Medicine Case Reports, 34, 101515. KarampoorS. AfrashtehF. LaaliA. 2021 Persistent hiccups after treatment of COVID-19 with dexamethasone: A case report Respiratory Medicine Case Reports 34 101515 Search in Google Scholar

19. Hill, A. V. (2012). Evolution, revolution and heresy in the genetics of infectious disease susceptibility. Philosophical Transactions of the Royal Society B: Biological Sciences, 367(1590), 840–849. HillA. V. 2012 Evolution, revolution and heresy in the genetics of infectious disease susceptibility Philosophical Transactions of the Royal Society B: Biological Sciences 367 1590 840 849 Search in Google Scholar

20. Patarčić, I., Gelemanović, A., Kirin, M., Kolčić, I., Theodoratou, E., Baillie, K. J., ... & Polašek, O. (2015). The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis. Scientific reports, 5(1), 16119. PatarčićI. GelemanovićA. KirinM. KolčićI. TheodoratouE. BaillieK. J. PolašekO. 2015 The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis Scientific reports 5 1 16119 Search in Google Scholar

21. Yucesoy, B., Kapici, S., Sercan, C., Yigitbasi, T., Emekli, N., & Ulucan, K. (2017). Determination of the Distribution of the rs2069514 and rs762551 Alleles of the Cyp1a2 Gene Related to Caffeine Metabolism in Professional Athletes. European Journal of Biology, 76(2), 69–73. YucesoyB. KapiciS. SercanC. YigitbasiT. EmekliN. UlucanK. 2017 Determination of the Distribution of the rs2069514 and rs762551 Alleles of the Cyp1a2 Gene Related to Caffeine Metabolism in Professional Athletes European Journal of Biology 76 2 69 73 Search in Google Scholar

22. Pijls, B. G., Jolani, S., Atherley, A., Dijkstra, J. I., Franssen, G. H., Hendriks, S., ... & Zeegers, M. P. (2022). Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients. F1000Research, 11. PijlsB. G. JolaniS. AtherleyA. DijkstraJ. I. FranssenG. H. HendriksS. ZeegersM. P. 2022 Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients F1000Research 11 Search in Google Scholar

23. Cohen, J. F., Korevaar, D. A., Matczak, S., Chalumeau, M., Allali, S., & Toubiana, J. (2021). COVID-19–related fatalities and intensive-care-unit admissions by age groups in Europe: a meta-analysis. Frontiers in Medicine, 7, 560685. CohenJ. F. KorevaarD. A. MatczakS. ChalumeauM. AllaliS. ToubianaJ. 2021 COVID-19–related fatalities and intensive-care-unit admissions by age groups in Europe: a meta-analysis Frontiers in Medicine 7 560685 Search in Google Scholar

24. Teker, A. G., Emecen, A. N., Girgin, S., Şimşek-Keskin, H., Şiyve, N., Sezgin, E., ... & Ünal, B. (2021). Türkiye’de Bir Üniversite Hastanesinde COVID-19 Olgularının Epidemiyolojik Özellikleri. Klimik Journal/Klimik Dergisi, 34(1). TekerA. G. EmecenA. N. GirginS. Şimşek-KeskinH. ŞiyveN. SezginE. ÜnalB. 2021 Türkiye’de Bir Üniversite Hastanesinde COVID-19 Olgularının Epidemiyolojik Özellikleri Klimik Journal/Klimik Dergisi 34 1 Search in Google Scholar

25. Jain, V., & Yuan, J. M. (2020). Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. International journal of public health, 65, 533–546. JainV. YuanJ. M. 2020 Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis International journal of public health 65 533 546 Search in Google Scholar

26. Yamamoto, N., Ariumi, Y., Nishida, N., Yamamoto, R., Bauer, G., Gojobori, T., ... & Mizokami, M. (2020). SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene, 758, 144944. YamamotoN. AriumiY. NishidaN. YamamotoR. BauerG. GojoboriT. MizokamiM. 2020 SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype Gene 758 144944 Search in Google Scholar

27. Gómez, J., Albaiceta, G. M., García-Clemente, M., López-Larrea, C., Amado-Rodríguez, L., Lopez-Alonso, I., ... & Coto, E. (2020). Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene, 762, 145102. GómezJ. AlbaicetaG. M. García-ClementeM. López-LarreaC. Amado-RodríguezL. Lopez-AlonsoI. CotoE. 2020 Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Gene 762 145102 Search in Google Scholar

28. Pinheiro, D. S., Santos, R. S., Jardim, P. C. V., Silva, E. G., Reis, A. A., Pedrino, G. R., & Ulhoa, C. J. (2019). The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients. PloS one, 14(8), e0221248. PinheiroD. S. SantosR. S. JardimP. C. V. SilvaE. G. ReisA. A. PedrinoG. R. UlhoaC. J. 2019 The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients PloS one 14 8 e0221248 Search in Google Scholar

29. Lenoir, C., Terrier, J., Gloor, Y., Curtin, F., Rollason, V., Desmeules, J. A., ... & Samer, C. F. (2021). Impact of SARS-CoV-2 infection (COVID-19) on cytochromes P450 activity assessed by the Geneva cocktail. Clinical Pharmacology & Therapeutics, 110(5), 1358–1367. LenoirC. TerrierJ. GloorY. CurtinF. RollasonV. DesmeulesJ. A. SamerC. F. 2021 Impact of SARS-CoV-2 infection (COVID-19) on cytochromes P450 activity assessed by the Geneva cocktail Clinical Pharmacology & Therapeutics 110 5 1358 1367 Search in Google Scholar

30. Kar, N., Barreto, S., & Chandavarkar, R. (2016). Clozapine monitoring in clinical practice: beyond the mandatory requirement. Clinical Psychopharmacology and Neuroscience, 14(4), 323. KarN. BarretoS. ChandavarkarR. 2016 Clozapine monitoring in clinical practice: beyond the mandatory requirement Clinical Psychopharmacology and Neuroscience 14 4 323 Search in Google Scholar

31. de Leon, J. (2004). Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature. The Journal of clinical psychiatry, 65(8), 18148. de LeonJ. 2004 Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature The Journal of clinical psychiatry 65 8 18148 Search in Google Scholar

32. Dotson, S., Hartvigsen, N., Wesner, T., Carbary, T. J., Fricchione, G., & Freudenreich, O. (2020). Clozapine toxicity in the setting of COVID-19. Psychosomatics, 61(5), 577. DotsonS. HartvigsenN. WesnerT. CarbaryT. J. FricchioneG. FreudenreichO. 2020 Clozapine toxicity in the setting of COVID-19 Psychosomatics 61 5 577 Search in Google Scholar

33. DiAngelo, Z., Berlin, J., Wang, S., Gutowski, B., & Bahnsen, R. (2022). (32) Clozapine Toxicity Following COVID-19 Infection: A Case Series. Journal of the Academy of Consultation-liaison Psychiatry, 63, S128–S128. DiAngeloZ. BerlinJ. WangS. GutowskiB. BahnsenR. 2022 32 Clozapine Toxicity Following COVID-19 Infection: A Case Series Journal of the Academy of Consultation-liaison Psychiatry 63 S128 S128 Search in Google Scholar

34. Reis, G., dos Santos Moreira-Silva, E. A., Silva, D. C. M., Thabane, L., Milagres, A. C., Ferreira, T. S., ... & Mills, E. J. (2022). Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. The Lancet Global Health, 10(1), e42–e51. ReisG. dos Santos Moreira-SilvaE. A. SilvaD. C. M. ThabaneL. MilagresA. C. FerreiraT. S. MillsE. J. 2022 Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial The Lancet Global Health 10 1 e42 e51 Search in Google Scholar

35. Tio, N., Schulte, P. F., & Martens, H. J. (2021). Clozapine intoxication in COVID-19. American Journal of Psychiatry, 178(2), 123–127. TioN. SchulteP. F. MartensH. J. 2021 Clozapine intoxication in COVID-19 American Journal of Psychiatry 178 2 123 127 Search in Google Scholar

36. Elfaki, I. (2022). The Impact of the Coronavirus (COVID-19) Infection on the Drug-Metabolizing Enzymes Cytochrome P450s. Drug Metabolism and Bioanalysis Letters Formerly: Drug Metabolism Letters, 15(2), 71–74. ElfakiI. 2022 The Impact of the Coronavirus (COVID-19) Infection on the Drug-Metabolizing Enzymes Cytochrome P450s Drug Metabolism and Bioanalysis Letters Formerly: Drug Metabolism Letters 15 2 71 74 Search in Google Scholar

37. Thorn, C. F., Aklillu, E., Klein, T. E., & Altman, R. B. (2012). PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenetics and genomics, 22(1), 73. ThornC. F. AklilluE. KleinT. E. AltmanR. B. 2012 PharmGKB summary: very important pharmacogene information for CYP1A2 Pharmacogenetics and genomics 22 1 73 Search in Google Scholar

38. Rahman, M. S., & Thomas, P. (2018). Interactive effects of hypoxia and PCB co-exposure on expression of CYP1A and its potential regulators in Atlantic croaker liver. Environmental toxicology, 33(4), 411–421. RahmanM. S. ThomasP. 2018 Interactive effects of hypoxia and PCB co-exposure on expression of CYP1A and its potential regulators in Atlantic croaker liver Environmental toxicology 33 4 411 421 Search in Google Scholar